Physician profile
Eli B Moses
NPI 1750515623
$11,942.77
in general payments reported to CMS, 2019-2025
28 companies · $1,064 in 2025
The $1,064 reported for 2025 was more than what 79% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,279 · 2020: $858 · 2021: $871 · 2022: $2,075 · 2023: $4,096 · 2024: $1,700 · 2025: $1,064.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,360 · Honoraria: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,360.15 |
| Honoraria | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $3,384.35 | 2020-2024 | Ahmed Glaucoma Valve, Kahook Dual Blade, Streamline |
| Glaukos Corporation | $1,275.07 | 2019-2025 | Idose, Photrexa Viscous and Photrexa |
| Biotissue Holdings INC. | $1,063.42 | 2019-2025 | |
| Bausch & Lomb Americas INC. | $670.94 | 2022-2025 | Envista Mx60 Iol, Vyzulta, Miebo |
| Mallinckrodt Hospital Products INC. | $668.68 | 2020-2025 | Acthar |
| Dompe US, INC. | $667.00 | 2021-2025 | Oxervate |
| Eyevance Pharmaceuticals LLC | $450.45 | 2019-2023 | Flarex |
| Oyster Point Pharma, INC. | $387.56 | 2022-2025 | Tyrvaya |
| Alcon Vision LLC | $380.56 | 2019-2025 | Tryptyr, Eysuvis |
| Kala Pharmaceuticals, INC. | $375.01 | 2020-2022 | |
| Harrow Eye, LLC | $336.05 | 2024-2025 | Vevye |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $307.11 | 2019-2021 | |
| Sight Sciences, INC. | $283.55 | 2020-2025 | Omni Surgical System, Sion Surgical Instrument |
| Novartis Pharmaceuticals Corporation | $263.41 | 2019-2023 | |
| Ani Pharmaceuticals, INC. | $218.06 | 2022-2024 | Purified Cortrophin Gel |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $192.40 | 2019-2025 | Cequa |
| Allergan, INC. | $192.27 | 2019-2022 | |
| Mallinckrodt Enterprises LLC | $127.74 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $124.17 | 2019-2024 | Tecnis Iol, Catalys System |
| Rxsight INC | $122.88 | 2023-2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Shire North American Group INC | $113.91 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $106.91 | 2024-2025 | Xdemvy |
| Abbvie INC. | $100.26 | 2022-2025 | |
| Amgen INC. | $47.94 | 2024 | Tepezza |
| Ocular Therapeutix, INC. | $28.80 | 2023 | Dextenza |
| Santen INC. | $20.97 | 2023 | Verkazia |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Aerie Pharmaceuticals, INC. | $13.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eli Moses listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.